期刊文献+

鲑降钙素、阿法骨化醇、碳酸钙联合应用治疗骨质疏松性股骨粗隆间骨折40例疗效分析 被引量:7

Evaluation of therapeutic effect of salmon calcitonin, alfacalcidol, calcium carbonate in the treatment of 40 cases of osteoporotic intertrochanteric fractures
下载PDF
导出
摘要 目的:比较鲑降钙素、阿法骨化醇、碳酸钙联合应用与单用鲑降钙素治疗骨质疏松性股骨粗隆间骨折的临床疗效。方法:将80例行闭合复位PFNA内固定术治疗的骨质疏松性股骨粗隆间骨折患者,随机分为实验组及对照组。分别给予肌注鲑降钙素+口服阿法骨化醇和碳酸钙和单纯肌注鲑降钙素。治疗6个月及1年后测定骨密度值及观察骨折愈合时间并进行比较。结果:实验组治疗6个月和1年后腰椎和股骨颈,Ward三角及大转子4个部位BMD较对照组均显著上升(P<0.05)。实验组与对照组比较,骨折愈合时间有显著性差异。结论:闭合复位PFNA内固定术治疗骨质疏松性股骨粗隆间骨折后,给予肌注鲑降钙素+口服阿法骨化醇和钙剂可显著提高患者的骨密度,缩短骨折的愈合时间,明显优于单纯给予肌注鲑降钙素的疗效。 To study the clinical efficacy of a monotherapy of salmon calcitonin or a combination therapy of salmon calcitonin with alfacalcidol and calcium carbonate on osteoporotic intertrochanteric fracture. Methods: Eighty patients with osteoporotic intertrochanteric fractures who received a reduction and internal fixation with PFNA were randomly divided into either experimental group or control one. Patients in experimental group were administrated with intramuscular salmon calcitonin plus oral alfacalcidol and calcium carbonate while only intramuscular salmon calcitonin was given in control group. BMD was measured again after 6 months or 1 year treatment, and fracture healing time was observed. The obtained data were statistically analyzed. Results: BMD of lumbar spine, neck of femur, trochiter and Ward's triangular area were more significantly increased in experimental group than in control group (P 〈 0.05). The comparisons of fracture healing time between two groups showed significant differences. Conclusion: After closed reduction and internal fixation of PFNA in osteoporotic intertrochanteric fracture, combination therapy of intramuscular salmon calcitonin plus oral alfacalcidol and calcium carbonate can significantly improve the patient's bone mineral density, shorten the healing time of fractures as compared with monotherapy of intramuscular salmon calcitonin.
出处 《上海医药》 CAS 2013年第9期24-27,共4页 Shanghai Medical & Pharmaceutical Journal
关键词 骨质疏松 股骨粗隆间骨折 阿法骨化醇 随机对照研究 osteoporosis intertrochanteric fractures alfacalcidol randomized controlled study
  • 相关文献

参考文献10

二级参考文献57

  • 1张智海,沈建雄,刘忠厚.中国人骨质疏松症诊断标准回顾性研究[J].中国骨质疏松杂志,2004,10(3):255-262. 被引量:110
  • 2石印玉,石鉴玉,沈培芝,陈东煜,李浩钢.四组中药防治实验性骨质疏松症的对比研究[J].中国骨质疏松杂志,1998,4(3):68-70. 被引量:14
  • 3孟迅吾.钙和骨质疏松症[J].中华内科杂志,2005,44(3):235-236. 被引量:19
  • 4孟迅吾.原发性骨质疏松症的诊断和防治[J].中华内分泌代谢杂志,2006,22(3):205-208. 被引量:43
  • 5Legg VA. Close look at renal osteodystrophy, nutritional disturbances, and inflammation. Am J Nurs, 2005,105 (6) : 40-49.
  • 6Martin K J, Olgaard K. Diagnosis, Assessment, and Treatment of Bone Turnover Abnormalities in Renal Osteodystrophy. Am J Kidney Dis, 2004,43 (3) : 558-565.
  • 7Hruska KA. Renal osteodystrophy. Baillieres Clin Endocrinol Metab, 1997,11 (1) : 165-194.
  • 8El-Kishawi AM, EI-Nahas AM. Renal Osteodystrophy : Review of the Disease and its Treatment. Saudi J Kidney Dis Transpl, 2006,17 (3) : 373-382.
  • 9Bervoets AR, Spasovski GB, Behets GJ, et al. Useful Biochemical Markers for Diagnosing Renal Osteodystrophy in Predialysis End-Stage Renal Failure Patients.
  • 10Zheng Falei, Yuan Qunsheng. Diagnosis and treatment of renal osteodystrophy and the progress of the new problem. Practical Clinical Journal of Hospital, 2006, 3(4): 2-5(in Chinese).

共引文献418

同被引文献56

引证文献7

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部